Sign up to save your podcasts
Or
Share Hechtman - Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mut...
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Hechtman - Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mut...
Full text - http://bit.ly/2yVSSPa
Oncotarget | Interview with Dr. Jaclyn Hechtman from the Department of Pathology Memorial Sloan Kettering Cancer Center, New York, NY, USAtalking about their Cover paper - Volume 7 Issue 32 - Oncotarget -"Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma"
Facebook - http://bit.ly/2xznxjV
Twitter - http://bit.ly/2xzWvsu
LinkedIn - http://bit.ly/2xzJ6kc
Pintrest - http://bit.ly/2xzX8SS
Reddit - http://bit.ly/2hoxI0N
www.Oncotarget.com
View all episodes
By Oncotarget Podcast
5
44 ratings
Full text - http://bit.ly/2yVSSPa
Oncotarget | Interview with Dr. Jaclyn Hechtman from the Department of Pathology Memorial Sloan Kettering Cancer Center, New York, NY, USAtalking about their Cover paper - Volume 7 Issue 32 - Oncotarget -"Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma"
Facebook - http://bit.ly/2xznxjV
Twitter - http://bit.ly/2xzWvsu
LinkedIn - http://bit.ly/2xzJ6kc
Pintrest - http://bit.ly/2xzX8SS
Reddit - http://bit.ly/2hoxI0N
www.Oncotarget.com